1,457
Views
12
CrossRef citations to date
0
Altmetric
Review Article

Towards a more comprehensive approach for a total economic assessment of vaccines?

1. The building blocks for a health economic assessment of vaccination

Article: 1335162 | Received 02 May 2017, Accepted 22 May 2017, Published online: 31 Aug 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Baudouin Standaert & Olivier Ethgen. (2023) Discounting health gain: a different view. Journal of Market Access & Health Policy 11:1.
Read now
Baudouin Standaert, Christophe Sauboin, Rodrigo DeAntonio, Alen Marijam, Jorge Gomez, Lijoy Varghese & Sharon Zhang. (2020) How to assess for the full economic value of vaccines? From past to present, drawing lessons for the future. Journal of Market Access & Health Policy 8:1.
Read now

Articles from other publishers (10)

Ahmed Mohy, Nicola Page, Welekazi Boyce & Jorge A. Gomez. (2023) Economic Evaluation of Rotavirus Vaccination in Children Aged Under Five Years in South Africa. Clinical Drug Investigation 43:11, pages 851-863.
Crossref
Baudouin Standaert. (2023) Comment on Postma et al. Predicted Public Health and Economic Impact of Respiratory Syncytial Virus Vaccination with Variable Duration of Protection for Adults ≥60 Years in Belgium. Vaccines 2023, 11, 990. Vaccines 11:11, pages 1646.
Crossref
Hong You, Malcolm K. Jones, Catherine A. Gordon, Alexa E. Arganda, Pengfei Cai, Harry Al-Wassiti, Colin W. Pouton & Donald P. McManus. (2023) The mRNA Vaccine Technology Era and the Future Control of Parasitic Infections. Clinical Microbiology Reviews 36:1.
Crossref
Yuying Tian, Zhuoya Deng & Penghui Yang. (2022) mRNA vaccines: A novel weapon to control infectious diseases. Frontiers in Microbiology 13.
Crossref
Ellen Rafferty, Laura Reifferscheid, Ali Assi & Shannon E. MacDonald. (2022) Using Health Economics to Inform Immunization Policy Across All Levels of Government. PharmacoEconomics - Open 6:5, pages 631-635.
Crossref
Ekkehard Beck, Eliana Biundo, Nancy Devlin, T. Mark Doherty, Antonio J. Garcia-Ruiz, Maarten Postma, Shazia Sheikh, Beata Smela, Mondher Toumi, Jurgen Wasem, Terry Nolan & David Salisbury. (2022) Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework. Vaccine 40:30, pages 4008-4016.
Crossref
Valérie Laigle, Maarten J Postma, Mira Pavlovic, Chiara Cadeddu, Ekkehard Beck, Anna Kapusniak & Mondher Toumi. (2021) Vaccine market access pathways in the EU27 and the United Kingdom − analysis and recommendations for improvements. Vaccine 39:39, pages 5706-5718.
Crossref
Pobitra Borah, Pran Kishore Deb, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Katharigatta N. Venugopala, Vinayak Singh, Pottathil Shinu, Snawar Hussain, Satyendra Deka, Balakumar Chandrasekaran & Da’san M. M. Jaradat. (2021) Perspectives on RNA Vaccine Candidates for COVID-19. Frontiers in Molecular Biosciences 8.
Crossref
Erez Yerushalmi, Priscillia Hunt, Stijn Hoorens, Christophe Sauboin & Richard Smith. (2019) Exploring the Use of a General Equilibrium Method to Assess the Value of a Malaria Vaccine: An Application to Ghana. MDM Policy & Practice 4:2, pages 238146831989434.
Crossref
Giulietta Maruggi, Cuiling Zhang, Junwei Li, Jeffrey B. Ulmer & Dong Yu. (2019) mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases. Molecular Therapy 27:4, pages 757-772.
Crossref